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Abstract
Background The challenges of advanced cancer have health
implications for patients and their family caregivers from di-
agnosis through end of life. The nature of the patient/caregiver
experience suggests that their mental and physical health may
be interdependent, but limited empirical evidence exists.
Purpose This study used social cognitive theory as a frame-
work to investigate individual and interpersonal influences on
patients’ and their family caregivers’ mental health, physical
health, and self-efficacy as individuals to manage the chal-
lenges of advanced disease over time.
Methods Patients and caregivers (484 patient-caregiver
dyads) completed surveys at baseline, 3 and 6 months. Lon-
gitudinal dyadic analysis techniques were used to examine (i)
the influence that patients and caregivers had on their own
mental health, physical health, and self-efficacy (actor effects)
and (ii) the influence that they had on each other’s health
outcomes (partner effects). We also examined the influence
of self-efficacy on mental and physical health over time.
Results Consistent with our hypotheses, each person’s mental
health, physical health, and self-efficacy had significant ef-
fects on their own outcomes over time (actor effects). Patients
and caregivers influenced one another’s mental and physical
health (partner effects), but not their self-efficacy. In addition,
patients and caregivers with higher self-efficacy had better
mental health, and their partners had better physical health.
Conclusions Patients’ and caregivers’ mental and physical
health were interdependent. Each person’s cancer-related
self-efficacy influenced their own mental and physical health.
However, a person’s self-efficacy did not influence the other
person’s self-efficacy.
Keywords Cancer .Dyads . Interdependence . Self-efficacy .
Health . Caregivers . APIM analyses . Social cognitive theory
Advanced cancer is now treated in outpatient settings, and as a
result, the burden of care has shifted from health professionals
to patients and their family caregivers [1]. Patients with ad-
vanced cancer and their family caregivers have more symp-
tom distress [2], greater disruptions in their daily lives [3], and
poorer mental [4] and physical health [5] than patients and
caregivers managing early-stage disease [5]. Yet, knowledge
about the experiences of patients with the most common types
of advanced cancer (i.e., lung, colorectal, breast, and prostate
cancer) and their family caregivers is limited, as most research
has focused primarily on patients with early-stage breast and
prostate cancer [6, 7]. Although there may be some variation
in patient care needs, advanced cancer often leads to a steady
deterioration in functioning, requiring adaptation by both the
patient and caregiver that is distinct from what is needed dur-
ing early-stage cancer [5]. As a result, longitudinal studies that
assess the mental and physical health of advanced cancer pa-
tients and their family caregivers over time are needed.
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Studies suggest that the responses of patients and their
family caregivers to the stress and demands associated with
advanced cancer are interrelated [8]; however, prior research
has often focused either on the patient or the caregiver as
isolated individuals [6]. Few studies have assessed the
patient-caregiver dyad (i.e., pair) as the unit of care. In a me-
ta-analysis, Hagedoorn and colleagues [8] found a moderate
correlation between patients’ and their partners’ distress sug-
gesting that they react as an emotional system to cancer rather
than as individuals. For example, patients’ mental health has
been associated with their family caregivers’ mental health
[9–14], while caregivers’ mental health has also been associ-
ated with poorer mental health in patients [15]. As the physical
functioning of patients with advanced cancer declines, the
physical health of their family caregivers can also decline
[16, 17], and physical deterioration among family caregivers
can negatively affect patients’ well-being [18].
The meta-analysis also identified a need for more research
on patients’ and caregivers’ experiences in advanced cancer.
Only three studies included in the meta-analysis had samples
consisting of advanced cancer patients [8]. Although there are
examples of more recent studies with advanced cancer patients
and their caregivers [19–22], notable gaps still remain in our
understanding of the interrelatedness of advanced cancer pa-
tients’ and their caregivers’ physical and mental health. This
research can inform the development of dyadic interventions
that will improve outcomes for both patients and caregivers
within the context of advancing and life-threatening disease.
Social cognitive theory provides a useful framework for
examining individual and interpersonal influences on cancer-
related outcomes [23]. The foundation of this theory is the
consideration of bidirectional influences between individual-
level factors (e.g., cognition, affect, and self-efficacy), envi-
ronment (e.g., family), and behavior. Based on social cogni-
tive theory, patients and caregivers can be viewed as part of a
shared physical and/or social environment that influences their
individual cognitions (and vice versa). Within this environ-
ment, patients and caregivers can observe one another’s expe-
riences with managing cancer/caregiving and can learn from
and be affected by one another. Consequently, proponents of
this theory could argue that it is important to consider the
effect patients and caregivers have on their own outcomes
(i.e., actor effects) and how each member of the dyad influ-
ences the outcomes of the other member (i.e., partner effects)
[24, 25]. Social cognitive theory has been used to examine the
patient’s experience of cancer [26], and it has been extended to
assess the caregiver’s influence on the patient’s outcomes
[27]. For example, when caregivers model positive care be-
haviors, this can have a direct interpersonal influence on the
ways patients cope with their cancer [27].
Self-efficacy, a key component of social cognitive theory,
may play an important role in managing the mental and phys-
ical consequences of cancer. A domain-specific construct,
self-efficacy in this context can be conceptualized as the de-
gree of confidence patients and caregivers have in their indi-
vidual ability to manage illness-related demands associated
with advanced cancer, and as a resource that can help attenuate
negative outcomes [28]. According to Bandura [29], individ-
ual perceptions of self-efficacy are expected to influence emo-
tional reactions and associated biological systems that regulate
well-being. A number of studies with patients and caregivers
have confirmed this relationship. Higher self-efficacy has
been associated with less emotional distress [30], less pain
[31, 32], reduced fatigue [33] and anxiety [30], fewer depres-
sive symptoms in cancer patients [32] and their caregivers [10,
34], and better quality of life [33]. Thus, self-efficacy is im-
portant for cancer patients to manage their illness and for
family caregivers to provide optimal care. Yet, our under-
standing of the possible interrelatedness of patients’ and care-
givers’ self-efficacy is limited.
Aims and Hypotheses
Since most studies have examined outcomes at only one point
[35–37], further research that examines the relationship be-
tween patients’ and caregivers’mental health, physical health,
and self-efficacy as they manage advanced cancer over time is
needed. Because we are studying patient-caregiver dyads
(pairs), we used terminology that is common in dyadic analy-
ses to formulate our aims (i.e., actor and partner effects) [38,
39]. The term “actor effect” refers to the influence that patients
or caregivers have on their own outcomes over time. The term
“partner effect” refers to the influence that an individual has
on the outcomes of their partner over time.
The first aim simultaneously examined actor and partner
effects of advanced cancer patients’ and their family care-
givers’ mental health, physical health, and self-efficacy over
time. For example, how does patients’ mental health at base-
line influence their own (actor effects) and their caregivers’
mental health (partner effects) at a subsequent time point? Our
specific hypotheses are as follows:
Hypothesis 1.1. Patients’ and caregivers’ mental health,
physical health, and self-efficacy will be significantly re-
lated to their own individual-level measures of those var-
iables over time (actor effects).
Hypothesis 1.2. Patients’ and caregivers’ mental health,
physical health, and self-efficacy will be significantly re-
lated to their dyadic partner’s individual-level measures
of those variables over time (partner effects).
Secondly, given the known associations between individu-
al self-efficacy and subsequent mental and physical health
[29] and the shared environments of patients and caregivers,
it is important to consider how one person’s self-efficacy
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influences the outcomes of the other within the patient-
caregiver dyad. Thus, the second aim simultaneously exam-
ined the effects of patients’ and caregivers’ self-efficacy on
their own and the other dyad members’ mental health and
physical health over time. For example, how does caregiver
self-efficacy to manage the demands of cancer at baseline
influence their own physical health (actor effects) and the
physical health of the patient (partner effects) at a later time
point? The associated hypotheses are as follows:
Hypothesis 2.1. Patients’ and caregivers’ level of self-
efficacy to manage the illness at baseline will be signifi-
cantly related to each person’s mental health and physical
health at 3- and 6-month assessments (actor effects).
Hypothesis 2.2. Patients’ and caregivers’ level of self-
efficacy to manage the illness at baseline will be signifi-
cantly related to the other member of the dyad’s mental
health and physical health at 3- and 6-month assessments
(partner effects).
Our study fills several gaps in the literature. Little research
has utilized social cognitive theory to explore actors’ and part-
ners’ influences of self-efficacy over time for advanced cancer
patients. In addition, we examined actor and partner effects on
important variables not assessed longitudinally in other stud-
ies (e.g., physical health and self-efficacy). Capturing these
effects will increase our understanding of how patients and
caregivers mutually influence each other over time.
Method
This study was a secondary analysis of data obtained from a
large multisite randomized clinical trial (RCT) that tested the
effects of a dyadic intervention on patient and caregiver out-
comes [40]. The psycho-educational intervention (i.e., The
FOCUS Program) was delivered to cancer patients and their
family caregivers jointly (as a pair) in their homes by masters-
prepared nurses. Both patients and their family caregivers
were actively involved in the intervention as suggested by
Badr and Krebs [6], which means that the intervention ad-
dressed both patients’ and caregivers’ concerns (physical
and emotional), facilitated their communication with one an-
other, and promoted adaptive coping by both individuals.
The RCT compared the effects of a brief (three-session)
program, a more extensive (six-session) program, and a con-
trol condition (usual clinic care) on psychological outcomes at
baseline (pre-intervention) and at 3 and 6 months from base-
line (post-intervention). The intervention was delivered be-
tween time 1 (baseline) and time 2 (3 months). Positive out-
comes associated with the intervention were hypothesized to
be less negative appraisal of illness, lower use of avoidant
coping, more healthy lifestyle behaviors, more dyadic
communication, higher self-efficacy, and higher quality of life
in patients or caregivers, or in the dyad as a unit. More infor-
mation about the study procedures and sample can be found
elsewhere [40]. The parent RCTstudy examined outcomes for
dyads who all participated in the RCT. This secondary analy-
sis is based on N=484 dyads and was conducted to analyze
more closely the extent to which patients and caregivers in-
fluenced one another’s mental and physical outcomes
over time (aim 1) and to determine the influence of
self-efficacy on their own or their partners’ mental and
physical health (aim 2).
Participants
Participants were patients with advanced cancer and their pri-
mary family caregivers. Eligible patients had either a new
diagnosis of advanced lung, colorectal, breast, or prostate can-
cer (i.e., stage III or IV) during the previous 6 months or
progression of their advanced disease during this time frame.
Patients also had to have a life expectancy ≥6 months (as
indicated by their oncologist), be 21 years of age or older, live
within 75 miles of one of the four participating cancer centers,
and have a family caregiver willing to participate in the study.
Family caregivers had to be 18 years or older and identified by
patients as their primary provider of emotional and/or physical
care. Caregivers diagnosed with a cancer within the past year
or who were receiving active treatment for cancer were
excluded.
Procedures
Eligible patients and their family caregivers (i.e., dyads) were
informed about the RCT by clinic staff at four cancer centers
in the Midwest. Dyads willing to participate were contacted
by research staff and scheduled for an initial home visit. Prior
to completing baseline instruments, participants signed a con-
sent form approved by Institutional Review Boards at the
patient’s cancer center and the University of Michigan (coor-
dinating institution). Patients along with their caregivers were
randomized to a psycho-educational intervention or control
condition [40]. Assessments were obtained at baseline (time
1), 3 months (time 2), and 6 months (time 3). Data were
collected in the home by research staff blinded to study group
assignments. A research staff member was present in the home
while patients and caregivers completed their questionnaires.
Patients and caregivers completed their questionnaires sepa-
rately, without consulting the other dyad member.
Measures
Both patients and caregivers completed the measures de-
scribed below. Internal consistency reliability coefficients
were assessed separately for patients and caregivers.
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Mental and Physical Health Patient mental and physical
health were assessed with the six-item emotional well-being
and seven-item physical well-being scales of the Functional
Assessment of Cancer Therapy Scale (FACT-G, Version 4)
[41]. Caregivers reported on their own mental and physical
health using the emotional and physical well-being subscales
of a slightly modified version of the FACT-G [28] (adapted
with permission of FACIT.org) that was used in our previous
studies [4, 40]. Internal consistency reliabilities for the
mental health measure at baseline, 3-month, and 6-
month assessments were .85, .84, and .86 for patients
and .81, .85, and .84 for caregivers. Reliabilities for the
physical health measure were .86, .84, and .85 for pa-
tients and .81, .81, and .80 for caregivers.
Self-Efficacy Participants’ self-efficacy was measured with
the 17-item Lewis Cancer Self-Efficacy Scale that assesses
patients’ and caregivers’ confidence about managing the ill-
ness [42]. The internal consistency reliabilities for the base-
line, 3-month, and 6-month assessments were .97, .97, and .98
for patients and .97, .98, and .98 for caregivers.
Covariates A number of demographic and medical factors,
which may influence relationships between patients’ and their
family caregivers’ responses to advanced cancer, were includ-
ed as covariates. Although age has been positively associated
with patients’ and caregivers’ mental health, it has been neg-
atively associated with their physical health [43]. Female pa-
tients [8, 44] and female caregivers [8, 44, 45] have reported
lower mental health than their male counterparts. Other factors
such as relationship of the caregiver to the patient (i.e., spousal
vs. non-spousal) and caregivers’ own health status (i.e., num-
ber of comorbidities) [46] have been associated with poorer
mental and physical health.
Demographic characteristics (e.g., age, gender, and rela-
tionship of caregiver) and medical characteristics (e.g., type
of cancer and comorbidities) were obtained from the demo-
graphic and health history sections of the Risk for Distress
Scale—adapted from the original Omega Clinical Screening
Interview [4, 40, 47] and with audits of patients’ medical
records. Since the current study was part of this larger RCT,
intervention condition was added as a covariate in all analyses.
We assessed for possible interactions between intervention
and key study components, and no significant interactions
were found.
Statistical Analyses
Frequencies and means were used to describe the sample.
Dyadic analyses were conducted using the actor-partner inter-
dependence model of patients’ and caregivers’ mental health,
physical health, and self-efficacy over time using path analysis
as outlined in Cook and Kenny [38]. For the path analysis, the
dyad is treated as the unit of analysis (i.e., the sample size is
the number of pairs of patients and caregivers). Both patient
and caregiver scores are modeled to determine the actor effect
of each person’s own variable (e.g., the effect of patient's
mental health at time 1 on patient's mental health at time 2)
[39]. We also examined partner effects of patients’ and care-
givers’ outcomes (e.g., the effect of caregiver's mental health
at time 1 on patient's mental health at time 2). Initial correla-
tion at time 1 was modeled as well as the correlation of the
error terms of the final time points in the model (e.g., error
terms for time 3 mental health between patient and caregiver)
[38, 48]. Further, because mental and physical health were
correlated (r=.41 for patients and r=.31 for caregivers at base-
line), we ran a combined analysis including both outcomes at
the same time. This allowed us to correlate the patients’ and
caregivers’ mental and physical health, avoiding issues of
multiple testing and inflated type I error.
Because standardized solutions using path analysis soft-
ware are not valid with dyadic data, we manually standardized
the data in order to present standardized coefficients as rec-
ommended by Kenny, Kashy, and Cook [39]. All analyses use
full information maximum likelihood (FIML) estimation,
which creates model estimates using all available data [49].
This allows us to include all participants, regardless of their
own missing time 2 and time 3 assessments, and regardless of
missing assessments from the other dyad member. We tested
the assumption of missing data to make sure data were miss-
ing at random (MAR) so that FIML techniques were valid.
This was done by comparing those who were missing and not
missing on study outcomes (e.g., mental and physical health),
predictors (self-efficacy), and demographic covariates. The
analyses controlled for age, gender, relationship of caregiver,
type of cancer, comorbidities of patients and caregiver, and
intervention group status for time 2 and time 3 outcomes.
Results
Sample Characteristics
Over 4 years, 906 patients were referred to the original RCT
[40]; 706 patient-caregiver dyads were eligible for the study
and 484 dyads completed time 1 (baseline) measures (enroll-
ment rate=68.6 %); 345 couples (71 %), 2 patients only, and 2
caregivers only completed time 2 assessments; and 303 cou-
ples (64 %), 4 patients only, and 1 caregiver only completed
time 3 assessments (see parent RCT for consort diagram) [40].
About 29 % of the sample died (n=100 patients, 3 caregivers)
or were too ill (n=39) to complete the study; the remaining
dropped out because they were too busy (n=16) or for various
other reasons (n=27). Analysis of the missing and valid data
which showed participants with missing values at time 2 or
time 3 did not differ on the study outcomes (e.g., mental and
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physical health), primary predictor (e.g., self-efficacy), or any
of the demographic variables. This suggests that the data met
the condition of MAR, and, therefore, FIML procedures for
handling missing data were valid and recommended [50].
The average age of patients was 60.5 (SD=10.9, range=
26–87) and for caregivers, it was 56.7 (SD=12.6, range=26–
95). Sixty-two percent of patients and 57% of caregivers were
female. Participants reported their race/ethnicity as Caucasian
(83 %), African-American (14 %), Hispanic (1 %), American
Indian (1 %), Asian (1 %), or other (1 %). The dyadic rela-
tionship was spouse/partners (74 %), relatives (19 %), or other
(7 %). The majority of patients had advanced breast cancer
(37%), followed by lung (24%), colorectal (23%), or prostate
(16 %) cancer. Over two-thirds (69 %) were receiving chemo-
therapy, while other treatments included hormones (17 %),
surgery (3 %), radiation (8 %), or watchful waiting (8 %)
(multiple responses were possible).
Tables 1 and 2 provide descriptive statistics and correla-
tions between main study variables (i.e., mental health, phys-
ical health, and self-efficacy) and background/demographic
factors (i.e., age, gender, relationship, cancer type, comorbid-
ities, and intervention group).
Actor and Partner Effects of Patient and Caregiver
Outcomes
For aim 1, we modeled the actor and partner effects of patients’
and caregivers’mental health, physical health, and self-efficacy.
Mental Health Patients’ and caregivers’ mental health were
significantly correlated at time 1 (r=.311, p<.01). Results
showed significant actor effects in both patients’ and care-
givers’ mental health over time (see Fig. 1). The association
of a person’s mental health at time 1 and their own mental
health at time 2 was different for caregivers and patients
(β= .635 vs. β= .520, chi-square difference (1)=8.30,
p<.05). However, caregivers and patients had similar actor
effects for mental health between time 2 and time 3 (β=.686
vs. β=.693, chi-square difference=1.00, p>.05). There were
three partner effects. Caregivers’ mental health at time 1 was
significantly associated with higher patients’ mental health at
time 2 (β=.115, p<.05). Caregivers’ mental health at time 2
was significantly associated with higher patients’ mental
health at time 3 (β=.079, p<.05). Patients’ mental health at
Table 1 Descriptives and correlations of patient outcomes and demographics/covariates
Mental health Physical health Self-efficacy
Descriptives T1
N=484
T2
N=347
T3
N=307
T1
N=484
T2
N=347
T3
N=307
T1
N=484
T2
N=347
T3
N=307
Means 16.61 17.55 17.00 19.36 19.97 19.97 138.89 133.04 133.37
SD 5.36 5.00 5.38 6.20 5.75 6.06 29.38 28.94 29.88
Correlations
Age r=.30* r=.23* r=.18* r=.27* r=.21* r=.12* r=.12* r=.15* r=.09
Gender t=3.67* t=2.37* t=2.15* t=3.97* t=1.70 t=1.10 t=1.07 t=0.37 t=−0.15
Male 17.74 (5.0) 18.36 (5.0) 17.93 (5.2) 20.77 (5.1) 20.63 (5.5) 20.45 (5.6) 134.72 (26.3) 133.77 (26.4) 133.06 (28.7)
Female 15.92 (5.4) 17.04 (5.0) 16.58 (5.5) 18.50 (6.6) 19.55 (5.9) 19.67 (6.3) 131.76 (31.1) 132.57 (30.5) 133.57 (30.7)
Relationship of caregiver t=0.89 t=0.60 t=−0.06 t=−2.16* t=0.36 t=−0.90 t=−0.90 t=0.76 t=−0.15
Spouse 16.94 (5.4) 17.81 (4.9) 17.08 (5.9) 18.43 (6.6) 20.14 (5.7) 19.45 (6.6) 131.06 (32.6) 134.94 (28.3) 132.95 (32.1)
Non-spouse 16.47 (5.4) 17.45 (5.1) 17.12 (5.2) 19.76 (6.0) 19.89 (5.8) 20.16 (5.9) 133.07 (27.9) 132.30 (29.2) 133.52 (29.1)
Type of cancer F=2.41 F=3.01* F=2.57 F=9.67* F=3.79* F=0.82 F=0.14 F=0.68 F=0.51
Prostate 18.02 (4.9) 19.20 (4.7) 18.47 (4.7) 23.03 (4.0) 22.46 (4.7) 21.14 (4.9) 134.98 (23.5) 137.63 (19.0) 135.00 (24.8)
Lung 16.48 (5.0) 17.61 (4.0) 16.69 (5.5) 19.19 (6.2) 19.54 (5.8) 19.66 (6.0) 132.99 (27.4) 130.38 (26.9) 136.41 (29.5)
Breast 15.95 (5.7) 16.72 (5.3) 16.28 (5.4) 18.23 (6.6) 19.45 (5.8) 19.59 (5.9) 132.14 (31.1) 132.86 (32.0) 131.76 (31.6)
Colon 16.89 (5.5) 17.70 (5.4) 17.89 (5.5) 19.13 (5.9) 19.67 (5.9) 20.09 (5.9) 132.64 (32.3) 133.35 (31.4) 131.49 (31.0)
Patient comorbidity t=−1.74 t=−0.04 t=−0.20 t=−0.86 t=0.94 t=−0.36 t=0.88 t=1.10 t=0.64
No 15.92 (5.7) 17.53 (5.2) 17.00 (5.9) 18.96 (6.2) 20.46 (5.7) 19.78 (6.6) 134.82 (29.8) 135.90 (28.7) 135.16 (30.3)
Yes 16.87 (5.2) 17.56 (4.9) 17.14 (5.2) 19.51 (6.2) 19.79 (5.8) 20.05 (5.9) 132.17 (29.2) 132.00 (29.0) 132.70 (29.8)
Caregiver comorbidity t=0.30 t=0.65 t=0.51 t=−1.48 t=0.44 t=0.36 t=−0.26 t=0.10 t=0.53
No 16.70 (5.5) 17.77 (5.0) 17.30 (5.9) 18.85 (6.8) 20.13 (6.0) 20.13 (6.2) 132.45 (30.2) 133.22 (27.1) 134.48 (28.1)
Yes 16.55 (5.3) 17.41 (5.0) 16.97 (5.2) 19.70 (5.8) 19.85 (5.6) 19.87 (6.0) 133.10 (28.9) 132.91 (30.2) 132.62 (31.1)
Cells contain means and standard deviations in parentheses unless otherwise noted
*p<.05
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time 2 was significantly related to caregivers’mental health at
time 3 (β=.085, p<.05).
Physical Health Results reported in Fig. 2 show similar
trends for physical health. There was a significant correlation
of physical health among dyad members at time 1 (r=.094,
p<.05). There were significant actor effects in patients’ and
caregivers’ physical health and these effects increased over
time. The association of a person’s physical health at time 1
and their own physical health at Time t was not different for
caregivers than for patients (β=.560 vs. β=.541, chi-square
difference (1)=0.40, p>.05). Similarly, the association of a
person’s physical health at time 2 and their own physical
health at time 3 was not different for caregivers than for pa-
tients (β=.646 vs. β=.606, chi-square difference=0.60,
p>.05). There was one significant partner effect. Patients’
physical health at time 1 was associated with increased care-
givers’ physical health at time 2 (β=.103, p<.05).
Self-Efficacy We modeled actor and partner effects of pa-
tients’ and caregivers’ self-efficacy over time (see
Figs. 1 and 2). Patients’ and caregivers’ self-efficacy
were not significantly correlated at time 1 (r=.086,
p>.05). Results showed strong actor effects of self-
efficacy over time for both patients and caregivers.
Caregivers had a stronger association of self-efficacy
between time 1 and time 2 than patients (β=.701 vs.
β=.604, chi-square difference=9.00, p<.05). However,
there was no difference in association of a person’s
self-efficacy at time 2 and their own self-efficacy at
time 3 between caregivers and patients (β=.725 vs.
β=.728, chi-square difference=0.01, p>.05). There were
no significant partner effects, showing that patients’ self-
efficacy at early time points did not influence care-
givers’ self-efficacy at subsequent time points, and that
caregivers’ self-efficacy at early time points did not in-
fluence patients’ self-efficacy at subsequent time points.
Longitudinal Effects of Self-Efficacy on Patients’
and Caregivers’ Outcomes
We explored longitudinal actor and partner effects of self-
efficacy (aim 2) by adding paths to the above models from
self-efficacy to mental health and to physical health outcomes
(see Figs. 1 and 2).
Actor Effects from Self-Efficacy to Outcomes Patients with
more self-efficacy at time 1 had higher mental health at time 2
(β=.217, p<.05). Similarly, patients with higher self-efficacy
at time 2 had higher mental health at time 3 (β=.135, p<.05).
Caregivers with higher self-efficacy at time 1 had higher men-
tal health at time 2 (β=.174, p<.05). Caregivers with higher
self-efficacy at time 2 had higher mental health (β=.190,
p<.05) at time 3. Higher caregiver self-efficacy at time 1
was related to higher caregiver physical health (β=.141,
p<.05) at time 2.
Partner Effects from Self-Efficacy to Outcomes We found
one significant partner effect. Higher patients’ self-efficacy at
time 2 was related to higher caregivers’ physical health
(β=.092, p<.05) at time 3 (see Fig. 2).
Discussion
This longitudinal study examined actor-partner effects of can-
cer patients’ and their family caregivers’ mental health, phys-
ical health, and self-efficacy during advanced stages of the
disease. Our hypotheses for aim 1 were partially confirmed.
Specifically, patients’ and caregivers’ mental and physi-
cal health had a significant influence on their own
health at subsequent time points (actor effects). Howev-
er, there were only a few partner effects (four out of a
possible eight), indicating that partner effects occurred,
but were limited. Partner effects were more common for
mental health outcomes (three out of four) compared to
physical health outcomes (one out of four). Our hypoth-
eses for aim 2 were also partially confirmed. Patients’
and caregivers’ self-efficacy influenced their own and
one another’s mental and physical health over time,
but results were not consistent across patients and care-
givers. These results partially support social cognitive
theory, which suggests that self-efficacy influences an
individual’s mental and physical well-being.
Influence of Patients and Caregivers on Own Outcomes
(Actor Effects)
Relationships over Time Findings indicated significant actor
effects in each person’s own level of mental health,
physical health, and self-efficacy over time. In most
cases, these actor effects strengthen over time indicating
that patients’ and caregivers’ initial levels were more
predictive of subsequent values. The actor effects for
patients’ and caregivers’ health outcomes suggests that
those with more mental and physical health problems
initially are at risk of having sustained problems over
time [51, 52], and warrant early intervention.
Mental Health Outcomes There were differences in actor
effects on some outcomes for patients and caregivers. Actor
effects for caregivers’ mental health were larger than for pa-
tients’mental health, suggesting there was less change in
caregiver mental health over time. The larger actor ef-
fects for caregivers may be due to the lack of mental
health services that caregivers use when suffering from
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emotional distress [53]. Caregivers are also less likely to
be referred to mental health services because they sel-
dom discuss concerns about their own mental health
with the patient’s oncologist or oncology social worker
(1). Furthermore, caregivers often report less social sup-
port than patients, which may result in lack of help
dealing with their own emotional needs while caring
for their loved one [52].
Table 2 Descriptives and correlations of caregiver outcomes and demographics/covariates
Mental health Physical health Self-efficacy
Descriptives T1
N=484
T2
N=347
T3
N=304
T1
N=484
T2
N=347
T3
N=304
T1
N=484
T2
N=347
T3
N=304
Means 16.61 17.55 17.10 24.02 24.07 24.56 133.07 132.32 131.87
SD 5.36 5.00 5.3844 4.15 4.12 3.76 27.56 30.32 28.89
Correlations
Age .12* .08 .04 .04 .05 −.01 .08 .14* .03
Gender t=−1.53 t=−1.31 t=−1.01 t=−1.17 t=−0.88 t=−2.15* t=−2.43* t=0.11 t=−0.18
Male 13.53 (5.0) 14.30 (5.5) 14.36 (5.3) 23.74 (4.3) 23.83 (4.3) 23.98 (4.2) 129.21 (31.0) 132.55 (19.0) 131.48 (28.5)
Female 14.27 (4.9) 15.10 (5.5) 15.00 (5.4) 24.19 (4.0) 24.23 (4.0) 24.93 (3.4) 135.44 (25.0) 132.17 (31.2) 132.10 (29.2)
Relationship of caregiver t=0.81 t=0.16 t=0.28 t=0.01 t=−1.02 t=−1.12 t=0.38 t=−1.20 t=−1.18
Spouse 14.28 (5.3) 14.87 (6.3) 14.90 (5.6) 24.02 (3.8) 23.70 (4.7) 24.16 (3.9) 133.79 (27.1) 129.14 (36.5) 128.59 (31.5)
Non-spouse 13.87 (5.1) 14.77 (5.2) 14.70 (5.3) 24.02 (4.3) 24.21 (3.9) 24.70 (3.7) 132.76 (27.8) 133.52 (27.6) 133.03 (27.9)
Type of cancer F=0.83 F=1.03 F=0.99 F=3.61* F=1.56 F=2.41 F=0.15 F=0.32 F=0.29
Prostate 14.13 (6.0) 14.39 (5.5) 14.93 (5.3) 24.84 (3.2) 24.70 (4.1) 25.20 (3.7) 131.08 (34.3) 132.37 (30.5) 134.71 (30.1)
Lung 13.47 (5.1) 14.06 (5.5) 13.90 (5.9) 23.30 (4.7) 23.38 (4.7) 24.09 (4.0) 132.95 (28.8) 129.71 (31.6) 129.94 (27.5)
Breast 14.40 (4.7) 15.26 (5.3) 15.27 (4.9) 24.61 (3.4) 24.42 (3.7) 25.06 (3.2) 133.83 (24.3) 133.69 (30.6) 131.41 (29.6)
Colon 14.00 (5.3) 15.16 (5.8) 14.73 (5.5) 23.68 (4.6) 23.94 (4.0) 23.83 (4.2) 133.27 (26.5) 133.10 (28.8) 132.73 (28.8)
Patient comorbidity t=0.05 t=−0.54 t=0.28 t=0.21 t=−0.16 t=0.05 t=1.86 t=−0.24 t=0.64
No 14.01 (5.2) 14.53 (5.6) 14.89 (5.7) 24.09 (4.6) 24.01 (4.2) 24.58 (4.5) 136.90 (27.5) 131.67 (32.8) 133.56 (28.6)
Yes 13.98 (5.2) 14.89 (5.5) 14.70 (5.3) 24.00 (4.0) 24.09 (4.1) 24.56 (3.4) 131.66 (27.5) 132.54 (29.4) 131.21 (29.0)
Caregiver comorbidity t=−1.65 t=−0.92 t=0.56 t=−2.71* t=2.03* t=2.31* t=−0.92 t=−1.09 t=0.11
No 13.51 (5.2) 14.46 (5.8) 14.96 (5.0) 24.65 (3.4) 24.62 (3.9) 25.16 (3.4) 131.66 (28.1) 130.17 (32.1) 132.08 (27.3)
Yes 14.30 (5.2) 15.02 (5.4) 14.61 (5.6) 23.61 (4.5) 23.70 (4.3) 24.15 (4.0) 134.00 (27.2) 133.78 (29.1) 131.71 (30.0)
Cells contain means and standard deviations in parentheses unless otherwise noted
*p<.05
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Influence of Patients and Caregivers on Their Partners’
Outcomes (Partner Effects)
Mental Health Outcomes Consistent with other reports [48],
there was a pattern of influence on one another’s mental health
outcomes, which originated from the caregiver. The mental
health of caregivers at time 1 subsequently influenced pa-
tients’ mental health at time 2, and patients’ mental health at
time 2 influenced caregivers’ mental health at time 3. This
indicates that each person’s responses affected the other. Sim-
ilar findings were reported in a large population-based study
that examined the association between cancer patients’ and
their partners’ quality of life [54]. Our findings are consistent
with social cognitive theory, which posits that the social envi-
ronment (e.g., important people in individuals’ lives) can in-
fluence how individuals cope with the stress of cancer [27].
These findings indicate that interventions should target the
mental health of both patients and caregivers to directly ben-
efit each individual, as well as have some influence on their
partners’ mental health.
Physical Health Outcomes Similarly, social environmental
influences were found on physical health outcomes, and these
pathways originated from the patient. The patient’s physical
well-being at time 1 had partner effects on the caregiver’s
physical well-being at time 2. A growing number of studies
have documented that stress associated with cancer can have a
negative effect on caregivers’ physical well-being by agitating
normal physiological processes [55] and decreasing care-
givers’ immune function [17] and self-care behaviors [16].
Self-Efficacy Outcomes There was no relationship between
patients’ and caregivers’ levels of self-efficacy at any of the
assessment times. Self-efficacy is behavior specific [56],
meaning that a person may feel efficacious performing one
behavior, but not another. Since the tasks required of the care-
giver are often different from the tasks required of the patient,
it is not surprising that patients’ and caregivers’ self-efficacy
scores were not related. The lack of a relationship may
indicate that when patients feel confident managing
their illness, it does not mean that their caregivers
are confident providing care or that caregivers receive
a boost in confidence emanating from patients’ confi-
dence. Since a component of self-efficacy is vicarious
experience [56], we may be more likely to see inter-
dependence in the self-efficacy between a patient’s pri-
mary and secondary caregiver (because of their similar
tasks caring for the patient), rather than between a
patient and caregiver.
This finding may also be a reflection of the individual-level
orientation of our self-efficacy measures. According to
Bandura [57], collective efficacy is a group-level construct,
representing shared beliefs about a group’s ability to achieve
a goal through collective action. In patient-caregiver dyads,
the knowledge, skills, and resources patients and caregivers
use to reach a shared goal (e.g., well-being) could be viewed
as an exercise of collective efficacy [58]. While their individ-
ual actions and their self-efficacy to reach that goal may differ,
social cognitive theory suggests that there is an association
between these individual-level factors (i.e., actions and self-
efficacy) and a measure of dyadic efficacy [23, 57, 59]. Future
research should examine the relationship between patient and
caregiver self-efficacy, dyadic efficacy (i.e., collective effica-
cy), and actions taken to reach shared goals within the context
of advanced cancer. Furthermore, because perceived interde-
pendence and group dynamics influence collective efficacy
[23, 57], health professionals should supplement information
tailored to both patients’ and caregivers’ specific needs with
support for key interpersonal factors (e.g., dyad relational
quality and communication) [60].
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Effects of Self-efficacy on Patients’ and Caregivers’
Outcomes
Self-Efficacy and Patient OutcomesAlthough there was not
an association between patients’ and caregivers’ self-efficacy,
self-efficacy was a strong predictor of outcomes over time,
which aligns with social cognitive theory. This was particular-
ly the case for the mental health outcomes. Patients with more
self-efficacy reported higher mental health at each subsequent
assessment time, and their caregivers’ reported higher physi-
cal health (time 3). Patients with higher self-efficacy may feel
more confident carrying out tasks by themselves, which may
help decrease strain and improve physical well-being of their
caregivers. Others have also reported that higher patient self-
efficacy for engaging in physical activities was associated
with higher patient mood [34]. Conversely, patients who are
not confident carrying out physical activities may be less ac-
tive and more dependent on their partners [34].
Self-Efficacy and Caregiver Outcomes Caregiver self-
efficacy was also related to positive outcomes. Caregivers with
more self-efficacy also had higher mental health at each subse-
quent assessment time possibly because self-efficacy served as
a buffer to help caregivers manage the distress associated with
caregiving [31] or because caregivers with more confidence felt
more mentally equipped to provide care.
Limitations
There are some limitations to this study that may have influ-
enced our findings. Our sample contained a group of patient-
caregiver dyads who agreed to be part of a randomized clinical
trial of a dyadic psycho-educational intervention to improve
mental and physical health of families affected by cancer and
who may have higher relationship functioning. In addition,
our patients and caregivers had relatively high SES (i.e., high
education and income) which may influence the resources
available for care, affecting coping and self-efficacy. These
associations should be tested and may be heightened for lower
SES patients and caregivers. Further, although we had ade-
quate representations of White and African-American fami-
lies, we were underrepresented for Hispanic and Asian fami-
lies. Families from collectivistic cultures may differ in terms
of the interactions and expectations of patients and caregivers.
Therefore, actor and partner effects should be compared
across different cultural groups and settings. In addition, al-
though we used dyadic analyses that assessed actor and part-
ner effects, some of our measures failed to capture conceptu-
ally dyadic processes. For example, we used measures that
assessed individual-level self-efficacy instead of measuring
collective self-efficacy which would have better matched So-
cial Cognitive Theory and our overall dyadic approach.
Finally, future studies should integrate biological indicators
of mental and physical health to improve validity.
Conclusions
Since advanced cancer patients and their family caregivers are
influenced by their own and their partner’s mental and physical
health, it is essential to view the patient-caregiver dyad as the
unit of care. Clinicians need to ask both patients and caregivers
how the illness is affecting them emotionally and physically
and refer them to support resources and to reliable websites
for information (e.g., National Cancer Institute or the American
Cancer Society). In some instances, it may be helpful to refer
caregivers to their primary care providers for a more in depth
mental and physical health assessment. Caregiver assessment,
training, and support need to be quality indicators that are inte-
grated into routine inpatient and outpatient care [61].
Our findings also indicate that self-efficacy is a key variable
to address in interventions offered to patients and their care-
givers [34]. Increasing patients’ and caregivers’ self-efficacy
will likely help improve outcomes for both members of the
dyad [33]. However, we need to tailor self-efficacy interven-
tions to the needs of the patient and caregiver within the dyad
and recognize that their self-efficacy is influenced by dyad-level
factors. The presence of high levels of individual self-efficacy
does not automatically lead to patient and caregiver success in
reaching shared goals [57]. Rather, dyads would benefit from
interventions that enhance interpersonal mechanisms and im-
prove their ability to cope with cancer together [59, 62].
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